Bausch Health Companies Inc saw a significant uptick in its stock price, reflecting growing optimism among investors.
Bausch Health Companies Inc (BHC.TO) experienced a notable increase in its stock price, closing up 4.65% in yesterday's session. This positive movement can be attributed to a series of favorable earnings estimate revisions and an upgrade in its stock rating.
Advertisement
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.09B
52W high
$11.08
52W low
$6.10
1W change
-11.06%
Beta
0.37
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to fall 11.1% over the next 12 months.
Consensus
Moderately BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-11.1% Upside
Current Price
C$7.88
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
54.0%
Annualized
90-Day Vol
67.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$9.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.36 | C$6.94 – C$10.08 |
| 60 trading days | C$8.88 | C$6.82 – C$11.55 |
| 90 trading days | C$9.42 | C$6.82 – C$13.01 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The upward trajectory of Bausch's stock suggests that investors are responding positively to improving earnings forecasts, making it a stock to watch closely.
Bausch Health's Market Cap Reaches CA$3.45 Billion
With a market capitalization of CA$3.45 billion, Bausch Health is gaining traction as analysts continue to revise their earnings estimates upward, indicating potential for sustained growth.
Bull case
Analysts have been raising their earnings estimates for Bausch, showing their confidence in the company’s future profitability. The recent upgrade to a Zacks Rank #2 (Buy) suggests that the stock is well-positioned for growth.
Bear case
Even with the positive momentum, investors should stay cautious. The stock has been volatile in the past, and any negative news could quickly reverse its gains.
Advertisement
Positive Earnings Outlook
Bausch Health's stock price increase can largely be attributed to a favorable shift in earnings estimates. Analysts are optimistic about the company's future earnings, with the consensus estimate for the current year rising by 7.41%. Such revisions often correlate with stock price movements, indicating that Bausch is on a positive trajectory.
Analyst Upgrades and Market Sentiment
The upgrade to a Zacks Rank #2 (Buy) reflects growing confidence in Bausch's business prospects. This rating change is significant as it suggests that institutional investors may increase their positions, further driving up the stock price. The Zacks Rank system is known for its strong historical performance, making this upgrade noteworthy for potential investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
